Thank you This live web event has ended. Thank you for attending. Contributors Katherine Tarlock, MD Dr. Katherine Tarlock earned her medical degree from Rosalind Franklin University in 2008. She then completed her residency in Pediatrics at Lucile Packard Hospital, Stanford University School of Medicine. She then went on to a fellowship in Pediatric Hematology & Oncology at Seattle Children’s Hospital/Fred Hutchinson Cancer Research Center in Seattle, and she completed her training in 2014. Following completion of her training, Dr. Tarlock joined the faculty at Seattle Children’s Hospital in the division of Hematology/Oncology and continued her research at the Fred Hutchinson Cancer Research Center. She is board certified in Pediatrics and Pediatric Hematology & Oncology. Dr. Tarlock’s clinical and research focus are centered in acute myeloid leukemia and myeloid diseases. She is particularly interested in genomic mutations that are involved in development of leukemia and may predict responses to therapy, as well as development of new therapies for acute myeloid leukemia, including immunotherapeutic strategies. She is also a member of the Children’s Oncology Group Myeloid Disease Committee.